LOPSL klinikiniai tyrimai Koloradas
15 tyrimai dėl LOPSL ieško dalyvių vietose Koloradas.
Miestai Koloradas
Oficialus tyrimo tekstas (anglų kalba)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Aurora
- Research Site, Denver
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Alpine Clinical Research Center - Boulder - 47th Street- Site Number : 8400005, Boulder
- Critical Care Pulmonary & Sleep Associates- Site Number : 8400081, Lakewood
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-10-01 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Lynn Institute of Denver, Aurora
Renkami dalyviai2 fazė
Amžius nuo 40 iki 85 · Visoms lytims · Atnaujinta 2026-09-30 · NCT07684820A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- National Jewish Health Medical Center, Denver
Renkami dalyviai2 fazė
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07759245An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- UCHealth - Medical Center of the Rockies, Loveland
Renkami dalyviai
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-17 · NCT06035120Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- National Jewish Health, Denver
Renkami dalyviai2 fazė
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-04 · NCT07059091eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Lakewood
Renkami dalyviai3 fazė
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-07-28 · NCT07177339MoblO2 to Maintain Oxygenation
- National Jewish Health, Denver
Renkami dalyviai
Amžius nuo 25 iki 95 · Visoms lytims · Atnaujinta 2026-07-22 · NCT07704567SPIROMICS Study of Early COPD Progression (SOURCE)
- National Jewish Health, Denver
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 30 iki 55 · Visoms lytims · Atnaujinta 2026-06-03 · NCT05033990Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
- Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora
Renkami dalyviai2 fazė
Amžius nuo 35 iki 89 · Visoms lytims · Atnaujinta 2026-05-15 · NCT05937854Phenotyping Resting and Exertional Right Ventricular Dysfunction Among Patients With Chronic Obstructive Pulmonary Disease
- University of Colorado Anschutz Medical Campus, Aurora
Renkami dalyviai
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-05-08 · NCT05896579Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary Disease
- University of Colorado Anschutz Medical Campus, Aurora
Renkami dalyviai
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-05-08 · NCT07576894Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Aurora
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-04-09 · NCT06961214PiMZ Longitudinal Cohort (PiMZ Logic)
- National Jewish Health, Denver
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-01-16 · NCT06505603PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
- University of Colorado, Denver
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2023-10-12 · NCT05306743Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.